Literature DB >> 22340575

Preconditioning of stem cells for the treatment of myocardial infarction.

Hui-He Lu1, Yi-Fei Li, Zheng-Qiang Sheng, Yi Wang.   

Abstract

OBJECTIVE: Poor stem cell survival is one of the obstacles for cell regeneration therapy post myocardial infarction (MI) and responsible for unsatisfactory therapeutic effectiveness. Various approaches to improve the status of these cells and increase cell survival have become research foci. The following article is a mini-review on the utilization of cell preconditioning for stem cell survival. DATA SOURCES: The data used in this review were mainly from the articles in Medline and PubMed published from 1990 to 2010. The search terms included "preconditioning, stem cell and myocardial infarction". STUDY SELECTION: Original articles and critical reviews selected were relevant to the review's theme.
RESULTS: The harsh ischemic and inflammatory microenvironment in the infarcted myocardium offers a significant challenge to the transplanted donor stem cells. Survival of stem cells following transplantation is affected by many factors, such as limited blood supply, nutritional deficiency, hypoxia, oxidative stress, and inflammation. Preconditioning methods have potent cytoprotective effects, which enables cells to maintain a "standby state" through programmed initiation of cell survival pathways.
CONCLUSIONS: The findings suggest that cell preconditioning can be used as an effective anti-apoptotic strategy and enable cells to withstand and survive the harsh environment after transplantation.

Entities:  

Mesh:

Year:  2012        PMID: 22340575

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  7 in total

1.  Influence of caspase-3 silencing on the proliferation and apoptosis of rat bone marrow mesenchymal stem cells under hypoxia.

Authors:  Ping Hua; Jialiang Liu; Jun Tao; Jianyang Liu; Songran Yang
Journal:  Int J Clin Exp Med       Date:  2015-02-15

Review 2.  In vitro augmentation of mesenchymal stem cells viability in stressful microenvironments : In vitro augmentation of mesenchymal stem cells viability.

Authors:  Fatemeh Amiri; Ali Jahanian-Najafabadi; Mehryar Habibi Roudkenar
Journal:  Cell Stress Chaperones       Date:  2014-12-20       Impact factor: 3.667

Review 3.  A revealing review of mesenchymal stem cells therapy, clinical perspectives and Modification strategies.

Authors:  Pardis Saeedi; Raheleh Halabian; Abbas Ali Imani Fooladi
Journal:  Stem Cell Investig       Date:  2019-09-25

4.  Anti-apoptotic effect of Nisin as a prebiotic on human mesenchymal stem cells in harsh condition.

Authors:  Atousa Namjoo; Ali Salimi; Pardis Saeedi; Raheleh Halabian; Asgar Emamgholi
Journal:  Cell Tissue Bank       Date:  2021-05-27       Impact factor: 1.522

Review 5.  The Clinical Status of Stem Cell Therapy for Ischemic Cardiomyopathy.

Authors:  Xianyun Wang; Jun Zhang; Fan Zhang; Jing Li; Yaqi Li; Zirui Tan; Jie Hu; Yixin Qi; Quanhai Li; Baoyong Yan
Journal:  Stem Cells Int       Date:  2015-05-26       Impact factor: 5.443

6.  Effects of Exendin-4 on bone marrow mesenchymal stem cell proliferation, migration and apoptosis in vitro.

Authors:  Hao Zhou; Dandan Li; Chen Shi; Ting Xin; Junjie Yang; Ying Zhou; Shunyin Hu; Feng Tian; Jing Wang; Yundai Chen
Journal:  Sci Rep       Date:  2015-08-07       Impact factor: 4.379

7.  Dual Preconditioning: A Novel Strategy to Withstand Mesenchymal Stem Cells against Harsh Microenvironments.

Authors:  Hamed Bashiri; Fatemeh Amiri; Ali Hosseini; Masoud Hamidi; Amaneh Mohammadi Roushandeh; Yoshikazu Kuwahara; Mohammad Ali Jalili; Mehryar Habibi Roudkenar
Journal:  Adv Pharm Bull       Date:  2018-08-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.